Canrenone
From Wikipedia, the free encyclopedia
|
Canrenone
|
|
| Systematic (IUPAC) name | |
| 10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione | |
| Identifiers | |
| CAS number | |
| ATC code | C03 |
| PubChem | |
| Chemical data | |
| Formula | C22H28O3 |
| Mol. mass | 340.456 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Canrenone is an aldosterone antagonist. The active form, and first metabolite of, Spironolactone.
|
||||||||||||||||||||

